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Original Article
Comparison of Veterans Affairs, Mayo, Brock classification 
models and radiologist diagnosis for classifying the malignancy of 
pulmonary nodules in Chinese clinical population
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Background: Several classification models based on Western population have been developed to help 
clinicians to classify the malignancy probability of pulmonary nodules. However, the diagnostic performance 
of these Western models in Chinese population is unknown. This paper aimed to compare the diagnostic 
performance of radiologist evaluation of malignancy probability and three classification models (Mayo 
Clinic, Veterans Affairs, and Brock University) in Chinese clinical pulmonology patients.
Methods: This single-center retrospective study included clinical patients from Tianjin Medical University 
Cancer Institute and Hospital with new, CT-detected pulmonary nodules in 2013. Patients with a nodule 
with diameter of 4–25 mm, and histological diagnosis or 2-year follow-up were included. Analysis of area 
under the receiver operating characteristic curve (AUC), decision curve analysis (DCA) and threshold of 
decision analysis was used to evaluate the diagnostic performance of radiologist diagnosis and the three 
classification models, with histological diagnosis or 2-year follow-up as the reference. 
Results: In total, 277 patients (286 nodules) were included. Two hundred and seven of 286 nodules (72.4%) 
in 203 patients were malignant. AUC of the Mayo model (0.77; 95% CI: 0.72–0.82) and Brock model 
(0.77; 95% CI: 0.72–0.82) were similar to radiologist diagnosis (0.78; 95% CI: 0.73–0.83; P=0.68, P=0.71, 
respectively). The diagnostic performance of the VA model (AUC: 0.66) was significantly lower than that 
of radiologist diagnosis (P=0.003). A three-class classifying threshold analysis and DCA showed that the 
radiologist evaluation had higher discriminatory power for malignancy than the three classification models. 
Conclusions: In a cohort of Chinese clinical pulmonology patients, radiologist evaluation of lung nodule 
malignancy probability demonstrated higher diagnostic performance than Mayo, Brock, and VA classification 
models. To optimize nodule diagnosis and management, a new model with more radiological characteristics 
could be valuable.
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Introduction 
Due to the widespread use of chest computed tomography 
(CT) and low-dose CT (LDCT), pulmonary nodules 
are encountered with increased frequency (1,2). This has 
created a great challenge to clinicians in discriminating 
malignant nodules  from benign nodules .  Several 
mathematical classification models based on clinical 
information and radiological characteristics have been 
developed to help clinicians to predict the malignancy 
probability of pulmonary nodules. The Mayo Clinic 
model was developed on the basis of a clinically relevant 
subset of patients in 1997 (3). The Veterans Affairs (VA) 
model that was designed in 2007 utilized data from the 
Department of Veterans Affairs administrative databases (4). 
The Brock model (PanCan model) was developed based 
on the Pan-Canadian Early Detection of Lung Cancer 
Study and validated using the British Columbia Cancer 
Agency (BCCA) cohort in 2013 (5). These models have 
demonstrated high predictive discrimination in independent 
cohorts (6-12).
Before choosing a classification model for pulmonary 
nodules, radiologists should think about the epidemiology 
of lung cancer in their region of the world. The above-
mentioned classification models have been developed in 
Western populations. It is for example well known that 
sub-solid nodules are more frequent in non-smoking 
patients and women in Asian populations (13,14). These 
sub-solid nodules are often subsequently diagnosed as 
adenocarcinoma. In addition, the Brock model was derived 
from a large lung cancer screening trial, in which small and 
benign nodules are frequent findings. The high diagnostic 
performance of the classification models in screening 
cohorts may not be automatically extrapolated to a clinical 
population, in which larger nodules are more frequently 
found (15). Furthermore, the question whether the models 
are better compared to radiologist evaluation remains, 
since these models have not been compared to radiologist 
diagnosis. In contrast to mathematical classification models, 
in China, radiologists make a subjective judgment about the 
probability of malignancy of nodules in a CT report based 
on the qualitative evaluation of radiological characteristics 
and clinical information. Usually, the radiologist evaluation 
reflects the radiologist’s ability to summarize nodule 
information and judge the malignancy probability based on 
their work experience. 
This study aimed to compare the diagnostic performance 
of radiologist diagnosis and three classification models 
in assessing the probability of malignancy of pulmonary 
nodules in a clinical setting population at a tertiary referral 
cancer center in China.
Methods
Study population
We conducted this retrospective study at Tianjin Medical 
University Cancer Institute and Hospital (TJMUCH). The 
institutional review board waived the need for informed 
consent because of its retrospective design and the use of 
anonymized data. 
We systematically collected all newly detected lung 
nodules in Tianjin Medical University Cancer Institute 
and Hospital between January 2013 and December 
2013. The inclusion criteria were: (I) newly detected 
pulmonary nodules on CT scans in 2013; (II) CT-derived 
nodule diameter between 4 and 25 mm; (III) nodules had 
confirmation of diagnosis (benign or malignant) based on 
histopathological result, or were considered benign when 
they either disappeared or reduced in size by at least 30% 
or remained stable for at least 2 years in CT follow-up; (IV) 
the patient’s clinical information needed to be complete. 
The exclusion criteria were: (I) patients with suspected or 
proven metastatic disease on chest CT, (II) nodules with 
unconfirmed diagnosis (for instance no, or too short follow-
up period or no pathology), and (III) patients without 
clinical information.
Information on pat ients ,  nodules ,  and cl inical 
characteristics was collected from the hospital information 
system. General patient characteristics included (I) gender; 
(II) age; (III) smoking history (smoking years, quit year); (IV) 
cancer history; and (V) family history of cancer. Nodule 
characteristics comprised (I) location (upper lobe, middle 
lobe, lower lobe); (II) size (average value of largest long 
diameter and short diameter measured in lung window); 
(III) margin (smooth, spiculated); (IV) nodule type (non-
solid, part-solid, solid); and (V) density (attenuation value 
of the largest region of interest). Clinical characteristics 
included (I) clinical diagnostic examination (CT, PET-
CT, and biopsy) and (II) histology results. All CT nodule 
characteristics were collected from the CT reports. The 
images were displayed using both mediastinal window 
setting (width, 350 HU; level, 40 HU) and lung window 
setting (width, 1,500 HU; level, −600 HU). 
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Radiologist diagnosis
To reflect real clinical practice, we used the CT diagnostic 
report to represent the diagnostic performance of 
radiologist evaluation. Each CT diagnostic report was 
evaluated by two radiologists (one junior, one senior). 
The final results were determined by consensus of the two 
radiologists in case of disagreement, and assigned to one 
of five categories: (I) benign; (II) probably benign; (III) 
undetermined; (IV) probably malignant; (VI) high suspicion 
of malignancy. These categories represent the radiologist 
classification of malignancy probability of the evaluated 
nodule in real clinical setting. There were totally 15 junior 
and 12 senior radiologists in our department involved in the 
CT evaluations.
Three classification models 
We used the clinical information and nodule characteristics 
to calculate the Mayo model, Brock model, and VA model 
outcomes, to assess malignancy probability. The detail 
calculation formulas of the three models are described in 
Appendix 1.
Decision analysis for the radiologist diagnosis and the three 
models
Decision curve analysis (DCA) (16,17) was used for 
the assessment of lung cancer diagnostic outcomes for 
radiologist diagnosis and all three models. For this analysis, 
we used R software version 3.0.3 (R Development Core 
Team, Vienna, Austria).
We also evaluated the malignancy risk thresholds 
of the Mayo model made by the American College of 
Chest Physicians (ACCP) (observe if <5%, indeterminate 
if 5–65%, surgery if >65%) (18), and the malignancy 
risk thresholds of the Brock model made by the British 
Thoracic Society (BTS) (observe if <10%, indeterminate 
if 10–70%, surgery if >70%) (19). The VA model also has 
recommended using malignancy risk thresholds (observe if 
<20%, indeterminate if 20–69%, surgery if >69%) (4). We 
defined the radiologist diagnosis risk thresholds based on 
the malignancy probability of the five categories (observe 
=1, indeterminate =2 or 3 or 4, surgery =5). The “Observe” 
group was recommended for 1-year CT follow-up, the 
“indeterminate” group was recommended for further 
examinations (PET-CT, contrast-enhanced CT, biopsy or 
short interval CT follow-up), and the “surgery” group was 
recommended for surgery.
Statistical analysis
Data were reported as numbers (%) for categorical 
variables. The Pearson’s Chi-square test was used to test 
for the difference between categorical variables. Normally 
distributed data were presented as mean [standard deviation 
(SD)] and were compared using Student’s t-test. Non-
normally distributed continuous variables were presented as 
medians [inter-quartile range (IQR)] and were evaluated by 
Mann-Whitney U test. A receiver operating characteristic 
(ROC) curve was constructed to assess the diagnostic 
accuracy of each model by calculating the area under the 
ROC curve (AUC) and 95% CI. To compare the AUC 
values between each two models, the non-parametric 
approach of DeLong et al. (20) was used, and Bonferroni 
correction was applied to adjust for multiple comparisons. 
Decision curve analysis (DCA) (16,17) was also used for 
the assessment of diagnostic outcomes for all models. All 
statistical analyses were performed using SPSS software 
version 20.0 (IBM, New York, US), R software version 
3.0.3 (R Development Core Team, Vienna, Austria), and 
MedCalc Statistical Software version 18.2.1 (Ostend, 
Belgium; http://www.medcalc.org; 2018). P values <0.05 
were considered to indicate statistical significance.
Results
Clinical and nodule characteristics
In total, 277 eligible patients with 286 nodules remained 
in our study. For nine cases had multiple nodules (5 benign 
and 4 malignant). In four cases (non-solid nodules) the two 
nodules present were surgically removed, because they were 
in the same lobe. The other five cases received CT follow-
up to confirm benign nature of the non-resected nodules. 
Mean patient age was 57.7 years (SD: 10.4). Patients with 
lung cancer were generally older than patients with benign 
nodules (59.4 vs. 52.9 years, P<0.001). Of the patients, 143 
(51.6%) were male and 156 (56.3%) were non-smokers. 
Eleven (4.0%) patients had a history of extra-thoracic 
cancer diagnosed more than 5 years ago, and 52 (18.8%) 
patients had a family history of cancer. There were 
32 cases of emphysema (11.6%), confirmed by CT 
diagnosis. The clinical characteristics of patients are 
summarized in Table 1. 
Among 286 nodules, 207 (72.4%) in 203 patients 
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were malignant. The majority of nodules were solid, 238 
(83.2%), of which 162 (68.4%) were malignant, while 
34 (34/35, 97.1%) part-solid nodules were malignant. 
Median nodule diameter of the malignant nodules was 
18.0 mm (IQR: 15.0–22.0 mm). This was significantly 
larger than the median diameter of 14.0 mm of benign 
nodules (IQR: 11.0–19.0 mm) (P=0.025). Malignant 
nodules were more likely to be spiculated than benign 
nodules (P<0.001). The CT characteristics of nodules are 
shown in Table 2.
Histopathological results of nodules
Among 286 nodules, 26 nodules were confirmed by 
CT follow-up (11 malignant nodules and 15 benign 
nodules), and 260 nodules were confirmed by surgery 
(196 malignant nodules and 64 benign nodules). The most 
common histopathological diagnosis was adenocarcinoma 
[N=163 (83.2%)], followed by squamous cell carcinoma 
[N=18 (9.2%)]. There were 64 histologically proven 
benign nodules. The most common type was hamartoma 
[N=20 (31.3%)]; other common histopathological types 
were inflammatory pseudotumors [N=13 (20.3%)], and 
tuberculosis [N=13 (20.3%)]. The histopathological results 
are shown in Table 3.
ROC curves for the radiologist diagnosis and three models
The area under the ROC curve (AUC, 95% CI) was used 
to compare the diagnostic performance between radiologist 
evaluation and the three models. For radiologist diagnosis, 
the AUC was 0.78 (0.73–0.83), for the Mayo model, 0.77 
(0.72–0.82), for the Brock model, 0.77 (0.72–0.82), and for 
the VA model, 0.66 (0.60–0.71) (Figure 1). The radiologist 
diagnosis was slightly better in the estimation of the 
probability of cancer than the three models, although it 
was not statistically significant compared with the Brock 
model (P=0.712), or Mayo model (P=0.676). The diagnostic 
performance of the VA model was significantly worse 
than the radiologist diagnosis and the other models (vs. 
radiologist diagnosis, P=0.003; vs. Mayo model, P<0.001; vs. 
Brock model, P=0.004).
Table 1 Clinical characteristics of the study patients
Clinical characteristics Total Benign Malignant P
No. of patients 277 74 203
Age in years, mean (SD) 57.7 (10.4) 52.9 (10.7) 59.4 (9.8) <0.001
Sex, n (%) 0.447
Male 143 (51.6) 41 (55.4) 102 (50.2)
Female 134 (48.4) 33 (44.6) 101 (49.8)
Smoking history, n (%) 0.363
No 156 (56.3) 45 (60.8) 111 (54.7)
Yes 121 (43.7) 29 (39.2) 92 (45.3)
Quit years, mean (SD) 1.3 (4.6) 0.6 (2.9) 1.5 (5.0) 0.034
Cancer history, n (%) 0.317
No 266 (96.0) 73 (98.6) 193 (95.1)
Yes 11 (4.0) 1 (1.4) 10 (4.9)
Family cancer history, n (%) 0.280
No 225 (81.2) 57 (77.0) 168 (82.8)
Yes 52 (18.8) 17 (23) 35 (17.2)
Emphysema, n (%) 0.514
No 245 (88.4) 68 (91.9) 177 (87.2)
Yes 32 (11.6) 6 (8.1) 26 (12.8)
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Decision analysis for the radiologist diagnosis and three 
models
Decision curve analysis was used to facil itate the 
comparison between different radiologist diagnosis and 
three classification models. As seen in Figure 2, the decision 
curve analysis graphically shows the clinical usefulness of 
each model based on a continuum of potential thresholds 
for lung cancer risk (x-axis) and the net benefit of using the 
model to risk stratify patients (y-axis) relative to assuming 
that no patient will have lung cancer. In this analysis, the 
radiologist diagnosis provided a larger net benefit across the 
range of lung cancer risk compared with the three models, 
at a threshold from about 0.22 to 0.88. Radiologist diagnosis 
had the highest discriminatory power for predicting 
malignant nodules, compared to the three risk classification 
models.
The three threshold decision analysis results are shown 
in Table 4. Radiologist diagnosis showed the highest 
negative predictive value [N=32 (80.0%)], while the 
three models showed higher positive predictive value 
(90.3–100%). The true positive rate of the radiologist’s 
diagnosis was much higher [157 (75.8%)] than the Mayo 
model [28 (13.5%)], the Brock model [2 (1.0%)] and the 
VA model [32 (15.5%)].
Discussion
Before choosing a classification model for the assessment 
of malignancy risk in pulmonary nodules, models should be 
executed with care and validated in local populations. In our 
retrospective study in a Chinese population, the AUC of the 
Mayo model and Brock model were similar to radiologist 
diagnosis. But, the three-class classifying threshold 
analysis and DCA showed that the radiologist evaluation 
had higher discriminatory power for malignancy than 
the three classification models. Therefore, for the three 
Table 2 CT characteristics of the nodules.
CT characteristics Total Benign Malignant P
No. of nodules 286 79 207
Nodule type, n (%) <0.001
Non-solid 13 (4.5) 3 (3.8) 10 (4.8)
Part-solid 35 (12.2) 1 (1.3) 34 (16.4)
Solid 238 (83.2) 75 (94.9) 163 (78.7)
Diameter (mm), median (IQR) 17.0 (13.0–21.0) 14.0 (11.0–19.0) 18.0 (15.0–22.0) 0.025
Location, n (%) 0.945
Upper lobe 163 (57.0) 44 (55.7) 119 (57.5)
Middle lobe 26 (9.1) 7 (8.9) 19 (9.2)
Lower lobe 97 (33.9) 28 (35.4) 69 (33.3)
Margin, n (%) <0.001
Smooth 43 (15.0) 31 (39.2) 12 (5.8)
Spiculated 243 (85.0) 48 (60.8) 195 (94.2)
Radiologist diagnosis, n (%)
Benign 40 (14.0) 32 (40.5) 8 (3.9)
Probably benign 12 (4.2) 6 (7.6) 6 (2.9)
Undetermined 39 (13.6) 14 (17.7) 25 (12.1)
Probably malignancy 17 (5.9) 6 (7.6) 11 (5.3)
High suspicion of malignancy 178 (62.2) 21 (26.6) 157 (75.8)
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common classification models used in our study, which 
were developed within Western populations, applicability to 
Asian populations should be optimized. 
Our AUC results showed that discriminatory ability of the 
Mayo model and the Brock model did not differ significantly 
from the radiologist diagnosis (Figure 2) but the diagnostic 
accuracy was lower than the results reported by Swensen 
et al. (Mayo, AUC 0.833±0.022 SE) (3), and McWilliams 
et al.  (Brock, AUC: 0.96; 95% CI: 0.93–0.98) (5). 
The AUC of the VA model (0.658, 95% CI: 0.600–0.713) 
was significantly lower than radiologist diagnosis (P=0.003) 
and also lower than the results reported by Michael et al. 
(VA, AUC: 0.78; 95% CI: 0.73–0.83) (3). The difference in 
accuracy between prior studies and ours can be explained by 
several factors. First, the Brock model (5) was trained on data 
from a lung cancer screening trial, and most of the nodules 
were smaller (median: 3.5 mm, 25th–75th percentile: 
2.8–5.0 mm) and were more often benign (98.5%) than 
our study (median: 17.0 mm, 25th–75th percentile: 
13.0–21.0 mm; 27.6% benign). The previous study also 
showed that the Brock classification model has limited 
use in predicting the malignancy of larger pulmonary 
nodules (15). Second, our inclusion criteria differed from 
the Mayo study. The Mayo study identified patients based 
on pulmonary nodules visible on chest X-rays, while our 
cohort was based on CT scan findings, and may have 
included more nodules. The malignancy proportion in our 
cohort (72.4%) was much higher than that in the Mayo 
study (23.2%), which inevitably led to an inaccuracy. Third, 
the VA model calculation formula included only four 
predictors: smoking history, years after quitting smoking, 
age, and diameter of the nodule. Contrary to the other 
models, the VA model did not include radiological features, 
this may explain its lower classification accuracy. Fourth, 
there are well-known differences in characteristics and in 
tumor types of lung cancer patients from Asian and Western 
populations. For example, the incidence of lung cancer is 
higher in middle-aged, non-smoking Asian women, and 
Table 3 Surgery pathology
Characteristic Pathology No. of nodules (%)
Benign  
(N=64)













Small cell 5 (2.6)
Large cell 1 (0.5)
Carcinoid 3 (1.5)
Clear cell tumors 1 (0.5)
Malignant* 5 (2.6)
*, the pathology result of 5 cases showed as malignant, but 
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        Brock (0.77, 0.72–0.82)
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Figure 1 Radiologist and model receiver operator characteristic 
curve accuracy.
Figure 2 Decision curve analysis for the radiologist diagnosis and 
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sub-solid nodules are more often detected and diagnosed as 
adenocarcinoma (2,13,14,21-24). The lower discriminatory 
power of the three classification models was also shown in 
some previous studies in Asian populations (7,8,12).
A ROC curve is designed as a discriminator, to illustrate 
the diagnostic ability of a binary classifier system and return 
an optimal threshold value (25). However, pulmonary 
nodule risk assessment is not a simple binary classification; 
often a three-class classifying system, based on malignancy 
risk thresholds, is recommended (26). Based on the result 
of using thresholds, only 28 (13.5%), 2 (1.0%), and 32 
(15.5%) out of 207 malignancies were predicted above the 
surgical threshold using the Mayo, Brock and VA models, 
respectively. The majority of the remaining nodules were 
indeterminate (Mayo model 85.5%; Brock model 93.7%; 
VA model 44.9%). In contrast to the three models, the 
radiologist diagnosis predicted 157 (75.8%) above the 
surgical threshold, 42 (20.3%) indeterminate, and 8 (3.9%) 
under the observe threshold out of 207 malignancies, 
thus showing a higher discriminatory power. The large 
proportion of patients classified as indeterminate in the 
three models could inevitably lead to several drawbacks, 
such as an increase in costs due to more PET-CT 
examinations, biopsies, and short interval CT follow-up 
examinations. Additionally, it also may result in delayed 
diagnosis or misdiagnosis. Some previous studies showed 
similar findings (27,28).
Previous studies have also reported that radiologist’s 
diagnosis as a means for predicting malignancy in 
pulmonary nodules is  more accurate than nodule 
classification models (29,30). However, this does not 
mean that the models are limited use. As an accessorial 
classification method, malignancy classification models can 
effectively avoid the subjective and unreliable for radiologist 
diagnosis, especially when evaluated by radiologists with 
little experience. But many parameters and characteristics 
need to be optimized before using in clinical, especially the 
best cut-off value for three-class classifying threshold.
Our study has a number of limitations. First, our study 
population may reflect a degree of selection bias since 
our hospital is a tertiary referral cancer center. Most 
patients were referred with suspected malignant nodules. 
For patients with very small nodules, we did not perform 
imaging follow-up at our center. Therefore, they were 








Benign (N=79) Malignant (N=207)
Number (%) Index Number (%) Index
Radiologist diagnosis Observe 1 32 (40.5) T.N 8 (3.9) F.N 80.0%
Indeterminate 2-4 26 (32.9) 42 (20.3) –
Surgery 5 21 (26.6) F.P 157 (75.8) T.P 88.2%
Mayo model Observe <5% 6 (7.6) T.N 2 (1.0) F.N 75.0%
Indeterminate 5–65% 70 (88.6) 177 (85.5) –
Surgery >65% 3 (3.8) F.P 28 (13.5) T.P 90.3%
Brock model Observe <10% 26 (32.9) T.N 11 (5.3) F.N 70.3%
Indeterminate 10–70% 53 (67.1) 194 (93.7) –
Surgery >70% 0 (0.0) F.P 2 (1.0) T.P 100.0%
VA model Observe <20% 48 (60.8) T.N 82 (39.6) F.N 36.9%
Indeterminate 20–69% 28 (35.4) 93 (44.9) –
Surgery 69% 3 (3.8) F.P 32 (15.5) T.P 91.4%
T.P, true positive; T.N, true negative; F.P, false-positive; F.N, false-negative; NPV, negative predictive value; PPV, positive predictive value.
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excluded in case they were not resected. Second, our 
radiologist diagnosis was based on the CT reports, signed 
by two radiologists (one junior, one senior), so the impact 
of radiologists’ experience could not be considered. In 
addition, radiologist diagnosis utilized CT characteristics 
including contrast enhancement and more image features 
(pleural indentation, vacuole, vascular invasion) of 
the nodule, which the three models did not take into 
consideration for their risk classification. Finally, due 
to the lack of PET information and quantitative nodule 
features, we did not evaluate nodule classification models 
that incorporated PET information (31,32) and radiomics 
features (33-35), which might be more accurate than the 
classification models evaluated in our study.
Conclusions
In conclusion, the AUC of the Mayo model and Brock 
model were similar to radiologist diagnosis, and the 
radiologist’s evaluation demonstrated better diagnostic 
performance in a Chinese clinical population. This 
suggests for the radiologists, it might of value to work on 
the development of a classification model based on more 
radiological features and the characteristics of population.
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Supplementary
Appendix 1 The calculation formulas of the 
three models
The Mayo model calculation formula was Logodds = 
(0.0391 * Age) + (0.7917 * Smoking) + (1.3388 * Cancer) + 
(0.12 74 * Diameter) + (1.0407 * Spiculation) + (0.7838 * 
upper) − 6.8272; Cancer probability = 100 * [e(Logodds) / (1 + 
e(Logodds))], where age is the patient’s age in years; Cigarettes 
=1 if the patient is a current or former cigarette smoker 
(otherwise =0), Cancer =1 if the patient has a history of 
an extrathoracic cancer that was diagnosed more than 
5 years ago (otherwise =0), Diameter is the largest diameter 
of the SPN in millimeters; spiculation =l if the edge of the 
SPN has spicules (otherwise =0), and upper =l if the SPN is 
located in an upper lobe (otherwise =0).
The VA model calculation formula was Logodds 
= −8.404 +2.061 * Smoke + 0.779 * Age / 10 + 0.112 * 
Diameter + 0.567 * Yearsquit/10; Cancer probability =100 * 
[e(Logodds) / (1 + e(Logodds))], where smoke is 1 if a current or 
former smoker (otherwise 0), Age/10 is age in years divided 
by 10, Diameter is the largest diameter of the nodule in 
millimeters, and yearsquit/10 is the number of years since 
quitting smoking divided by 10.
The Brock model calculation formula was Logodds = 
[0.0287 * (Age − 62)] + Sex + FamilyHistoryLungCa + 
Emphysema – {5.3854 * [(Nodulesize/10)−0.5 − 1.58113883)] 
+ Noduletype + (0.6581 * NoduleUpperLung) – [0.0824 * 
(Nodulecount − 4)] + Spiculation − 6.7892}; Cancer 
probability = 100 * {e(Logodds) / [1 + e(Logodds)]}; Female =0.6011 
and male =0, FamilyHistoryLungCa =0.2961 if the patient 
has a family cancer history (otherwise =0); Emphysema 
=0.2953 if the patient CT image showed emphysema 
(otherwise =0); Nonsolid =-0.1276, sub-solid =0.377, solid 
=0; NoduleUpperLung =l if the SPN is located in an upper 
lobe (otherwise =0), and spiculation =0.7729 if the edge of 
the nodule has spicules (otherwise =0).
